Two Sigma Advisers’s Profound Medical PROF Stock Holding History

Two Sigma Advisers’s Portfolio PROF Stock Details PROF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,000	Closed	-$220K	–	2769
2021 Q3	$220K	Sell	15,000 -15,000	-50%	-$229K	﹤0.01%	2217
2021 Q2	$491K	Sell	30,000 -17,700	-37%	-$329K	﹤0.01%	1945
2021 Q1	$961K	Buy	47,700 +5,400	+13%	+$129K	﹤0.01%	1669
2020 Q4	$870K	Buy	42,300 +11,500	+37%	+$212K	﹤0.01%	1630
2020 Q3	$543K	Buy	30,800 +11,400	+59%	+$181K	﹤0.01%	1787
2020 Q2	$329K	Buy	+19,400	New	+$245K	﹤0.01%	2085

Other funds holding PROF

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return

TIM

Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Two Sigma Advisers's PROF Position: Q4 2021 in Review

Two Sigma Advisers sold out of Profound Medical (PROF) in Q4 2021, closing a stake of 15,000 shares — an estimated $220K sold.

Two Sigma Advisers first reported a position in PROF in Q2 2020 and held it in 6 quarters. The position peaked at $961K in Q1 2021. 46 funds tracked by Wall St. Rank hold PROF as of Q4 2021.

Two Sigma Advisers reported no remaining Profound Medical position as of Q4 2021 after selling out during the quarter.
Two Sigma Advisers sold 15,000 Profound Medical shares in Q4 2021, an estimated $220K.
Two Sigma Advisers first reported a position in Profound Medical in Q2 2020 and held it in 6 quarters.
Two Sigma Advisers's Profound Medical position peaked at $961K in Q1 2021.
46 funds tracked by Wall St. Rank held Profound Medical as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.